KeyBanc Capital Markets initiated coverage on Axonics Modulation with a new price target

7/13/23 7:29:51 AM ET

Medical/Dental Instruments

Health Care

KeyBanc Capital Markets initiated coverage of Axonics Modulation with a rating of Overweight and set a new price target of $70.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$AXNX

Date	Price Target	Rating	Analyst
1/9/2024		Outperform → Peer Perform	Wolfe Research
7/19/2023	$69.00	Outperform	Robert W. Baird
7/13/2023	$70.00	Overweight	KeyBanc Capital Markets
5/23/2023	$75.00	Buy	CL King
4/14/2023	$75.00	Buy	Mizuho
3/24/2023	$71.00	Hold → Buy	Needham
10/21/2022	$85.00	Outperform	RBC Capital Mkts
10/12/2022	$75.00	Hold	Jefferies